|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/22 | |||
| A61P 35/00 | |||
| A61K 31/282 |
| (11) | Patento numeris | 3197493 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15777810.1 |
| Europos patento paraiškos padavimo data | 2015-09-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-02 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-03-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/052247 |
| Data | 2015-09-25 |
| (87) | Numeris | WO 2016/049470 |
| Data | 2016-03-31 |
| (30) | Numeris | Data | Šalis |
| 201462055203 P | 2014-09-25 | US |
| (72) |
GYURIS, Jeno, US
LERNER, Lorena, US
LIN, Jie, US
|
| (73) |
Aveo Pharmaceuticals Inc.,
1 Broadway 14th Floor, Cambridge, MA 02142,
US
|
| (54) | METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT |
| METHODS OF REVERSING CACHEXIA AND PROLONGING SURVIVAL COMPRISING ADMINISTERING A GDF15 MODULATOR AND AN ANTI-CANCER AGENT |